ARIAD PHARMACEUTICALS INC
DelistedCIK 884731fmd_1J0KAWD7ZQQNC6NKNB2HANRHJGManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2009 to Sep 30, 2016, 27 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|
| Total revenues | 8 | 179 | 25 | 1 | 46 | 105 | 119 |
| Cost of revenue | – | – | – | – | 10 | 5 | 2 |
| Gross profit | – | – | – | – | 36 | 100 | 117 |
| Research and development | 63 | 58 | 78 | 145 | 163 | 121 | 171 |
| Selling, general and administrative | – | – | 24 | 61 | 147 | 140 | 163 |
| Total operating expenses | 80 | 74 | 102 | 206 | 319 | 266 | 336 |
| Operating income | (72) | 105 | (77) | (205) | (274) | (160) | (217) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 8 | 18 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (8) | (20) | (47) | (16) | (0) | (2) | (17) |
| Income before taxes | – | – | (124) | (221) | (274) | (162) | (235) |
| Income tax expense | – | – | – | – | 0 | 1 | (3) |
| Net income from continuing operations | – | – | – | – | (274) | (163) | (231) |
| Net income | (80) | 85 | (124) | (221) | (274) | (163) | (231) |